Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery

Yoosoo Yang, Yeonsun Hong, Eunji Cho, Gi Beom Kim, In-San Kim

Research output: Contribution to journalReview article

26 Citations (Scopus)

Abstract

Membrane proteins are of great research interest, particularly because they are rich in targets for therapeutic application. The suitability of various membrane proteins as targets for therapeutic formulations, such as drugs or antibodies, has been studied in preclinical and clinical studies. For therapeutic application, however, a protein must be expressed and purified in as close to its native conformation as possible. This has proven difficult for membrane proteins, as their native conformation requires the association with an appropriate cellular membrane. One solution to this problem is to use extracellular vesicles as a display platform. Exosomes and microvesicles are membranous extracellular vesicles that are released from most cells. Their membranes may provide a favourable microenvironment for membrane proteins to take on their proper conformation, activity, and membrane distribution; moreover, membrane proteins can cluster into microdomains on the surface of extracellular vesicles following their biogenesis. In this review, we survey the state-of-the-art of extracellular vesicle (exosome and small-sized microvesicle)-based therapeutics, evaluate the current biological understanding of these formulations, and forecast the technical advances that will be needed to continue driving the development of membrane protein therapeutics.

Original languageEnglish
Article number1440131
JournalJournal of Extracellular Vesicles
Volume7
Issue number1
DOIs
Publication statusPublished - 2018 Jan 1

Fingerprint

Membrane Proteins
Exosomes
Membranes
Therapeutics
Extracellular Vesicles
Antibodies
Research
Pharmaceutical Preparations
Proteins

Keywords

  • Exosomes
  • Extracellular vesicle
  • Membrane protein
  • Microdomain
  • Protein therapeutics

ASJC Scopus subject areas

  • Histology
  • Cell Biology

Cite this

Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery. / Yang, Yoosoo; Hong, Yeonsun; Cho, Eunji; Kim, Gi Beom; Kim, In-San.

In: Journal of Extracellular Vesicles, Vol. 7, No. 1, 1440131, 01.01.2018.

Research output: Contribution to journalReview article

@article{c4ccd3e338cc4beea6d8b17e503b4036,
title = "Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery",
abstract = "Membrane proteins are of great research interest, particularly because they are rich in targets for therapeutic application. The suitability of various membrane proteins as targets for therapeutic formulations, such as drugs or antibodies, has been studied in preclinical and clinical studies. For therapeutic application, however, a protein must be expressed and purified in as close to its native conformation as possible. This has proven difficult for membrane proteins, as their native conformation requires the association with an appropriate cellular membrane. One solution to this problem is to use extracellular vesicles as a display platform. Exosomes and microvesicles are membranous extracellular vesicles that are released from most cells. Their membranes may provide a favourable microenvironment for membrane proteins to take on their proper conformation, activity, and membrane distribution; moreover, membrane proteins can cluster into microdomains on the surface of extracellular vesicles following their biogenesis. In this review, we survey the state-of-the-art of extracellular vesicle (exosome and small-sized microvesicle)-based therapeutics, evaluate the current biological understanding of these formulations, and forecast the technical advances that will be needed to continue driving the development of membrane protein therapeutics.",
keywords = "Exosomes, Extracellular vesicle, Membrane protein, Microdomain, Protein therapeutics",
author = "Yoosoo Yang and Yeonsun Hong and Eunji Cho and Kim, {Gi Beom} and In-San Kim",
year = "2018",
month = "1",
day = "1",
doi = "10.1080/20013078.2018.1440131",
language = "English",
volume = "7",
journal = "Journal of Extracellular Vesicles",
issn = "2001-3078",
publisher = "Taylor and Francis Ltd.",
number = "1",

}

TY - JOUR

T1 - Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery

AU - Yang, Yoosoo

AU - Hong, Yeonsun

AU - Cho, Eunji

AU - Kim, Gi Beom

AU - Kim, In-San

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Membrane proteins are of great research interest, particularly because they are rich in targets for therapeutic application. The suitability of various membrane proteins as targets for therapeutic formulations, such as drugs or antibodies, has been studied in preclinical and clinical studies. For therapeutic application, however, a protein must be expressed and purified in as close to its native conformation as possible. This has proven difficult for membrane proteins, as their native conformation requires the association with an appropriate cellular membrane. One solution to this problem is to use extracellular vesicles as a display platform. Exosomes and microvesicles are membranous extracellular vesicles that are released from most cells. Their membranes may provide a favourable microenvironment for membrane proteins to take on their proper conformation, activity, and membrane distribution; moreover, membrane proteins can cluster into microdomains on the surface of extracellular vesicles following their biogenesis. In this review, we survey the state-of-the-art of extracellular vesicle (exosome and small-sized microvesicle)-based therapeutics, evaluate the current biological understanding of these formulations, and forecast the technical advances that will be needed to continue driving the development of membrane protein therapeutics.

AB - Membrane proteins are of great research interest, particularly because they are rich in targets for therapeutic application. The suitability of various membrane proteins as targets for therapeutic formulations, such as drugs or antibodies, has been studied in preclinical and clinical studies. For therapeutic application, however, a protein must be expressed and purified in as close to its native conformation as possible. This has proven difficult for membrane proteins, as their native conformation requires the association with an appropriate cellular membrane. One solution to this problem is to use extracellular vesicles as a display platform. Exosomes and microvesicles are membranous extracellular vesicles that are released from most cells. Their membranes may provide a favourable microenvironment for membrane proteins to take on their proper conformation, activity, and membrane distribution; moreover, membrane proteins can cluster into microdomains on the surface of extracellular vesicles following their biogenesis. In this review, we survey the state-of-the-art of extracellular vesicle (exosome and small-sized microvesicle)-based therapeutics, evaluate the current biological understanding of these formulations, and forecast the technical advances that will be needed to continue driving the development of membrane protein therapeutics.

KW - Exosomes

KW - Extracellular vesicle

KW - Membrane protein

KW - Microdomain

KW - Protein therapeutics

UR - http://www.scopus.com/inward/record.url?scp=85044102529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044102529&partnerID=8YFLogxK

U2 - 10.1080/20013078.2018.1440131

DO - 10.1080/20013078.2018.1440131

M3 - Review article

AN - SCOPUS:85044102529

VL - 7

JO - Journal of Extracellular Vesicles

JF - Journal of Extracellular Vesicles

SN - 2001-3078

IS - 1

M1 - 1440131

ER -